Potentially avoidable hospitalizations: inequalities in rates between US socioeconomic groups

American Journal of Public Health
G PappasG F Fisher

Abstract

The National Hospital Discharge Survey (NHDS) was used to evaluate potentially avoidable hospital conditions as an indicator of equity and efficiency in the US health care system. With the use of 1990 data from the NHDS, the National Health Interview Survey, and the census, national rates of hospitalization were calculated for avoidable conditions by age, race, median income of zip code, and insurance status. An estimated 3.1 million hospitalizations were for potentially avoidable conditions. This was 12% of all hospitalizations in 1990 (excluding psychiatric admissions, women with deliveries, and newborns). Rates of potentially avoidable hospitalizations were higher for persons living in middle- and low-income areas than for persons living in high-income areas, and were higher among Blacks than among Whites. These class and racial differences were also found among the privately insured. Differences among income and racial groups for persons aged 65 and over were not significant. Inequalities in potentially avoidable hospitalizations suggest inequity and inefficiency in the health care delivery system. Avoidable hospital conditions are a useful national indicator to monitor access to care.

Associated Clinical Trials

References

Mar 11, 1976·The New England Journal of Medicine·D D RutsteinE B Perrin
Nov 4, 1992·JAMA : the Journal of the American Medical Association·J S WeissmanA M Epstein
Jul 23, 1992·The New England Journal of Medicine·T Bodenheimer
Feb 15, 1991·Annals of Internal Medicine·J S WeissmanA M Epstein
Oct 23, 1991·JAMA : the Journal of the American Medical Association·B Starfield
Jan 1, 1990·Health Affairs·J Billings, N Teicholz
Apr 1, 1990·American Journal of Public Health·R PokrasE J Graves
Jul 26, 1995·JAMA : the Journal of the American Medical Association·A B BindmanA Stewart
Jan 1, 1995·International Journal of Health Services : Planning, Administration, Evaluation·C Casanova, B Starfield
Jan 1, 1994·Journal of Health Care for the Poor and Underserved·K J Rask
Jan 1, 1994·Health Affairs·D RowlandP Long
Jan 1, 1993·Health Affairs·J BillingsL Newman
Jan 11, 1996·The New England Journal of Medicine·J K Iglehart
Apr 25, 1996·The New England Journal of Medicine·S A Schroeder

❮ Previous
Next ❯

Citations

Nov 14, 2007·Archives of Internal Medicine·Markus H Schafer, Kenneth F Ferraro
Sep 24, 2008·Archives of Internal Medicine·Kevin Fiscella, Ronald M Epstein
Nov 3, 2010·Archives of Pediatrics & Adolescent Medicine·Jeffrey O TomRita Mangione-Smith
Sep 8, 2000·Journal of Urban Health : Bulletin of the New York Academy of Medicine·A P Polednak
Aug 31, 2011·Journal of Community Health·Preethy NayarFang Yu
May 5, 2009·Journal of Medical Systems·Joshua R Vest
Nov 2, 2011·The Journal of Behavioral Health Services & Research·Hilary F ByrnesCarolyn D Keagy
Jan 10, 2004·The Journal of Allergy and Clinical Immunology·Robert A NathanTrudy B Pendergraft
Nov 25, 2003·Patient Education and Counseling·Julie A GazmararianDavid W Baker
Jun 17, 1998·Applied Nursing Research : ANR·G L Ingersoll
Jun 12, 2004·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Lucinda OrsiniKhalid Kamal
May 25, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Henry MilgromFrederick Wamboldt
Feb 13, 2001·Health & Place·T C RickettsT Carey
Jun 22, 2012·Health Economics, Policy, and Law·Pui Hing ChauKam Che Chan
Jun 16, 2006·Ethnicity & Health·James N Laditka, Sarah B Laditka
Jun 1, 2000·Ethnicity & Health·F M Trevino
Jan 16, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Harish JastiMichael J Fine
Aug 17, 2010·European Journal of Public Health·Philippe TuppinHubert Allemand
Oct 26, 1999·The Journal of Nursing Administration·J V Belcher, B Alexy
Oct 22, 2008·Journal of Public Health Management and Practice : JPHMP·Leiyu ShiJenna Tsai
Nov 9, 2011·Health Care Management Review·Naleef FareedJonathan P DeShazo
Jul 5, 2003·The Milbank Quarterly·Nelda McCallStanley Moore
Nov 5, 2003·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Mark F GuagliardoJill G Joseph
May 8, 1999·The Journal of School Health·J R MeurerV George
Jun 1, 2000·The Western Journal of Medicine·F A MillerH Waitzkin
Nov 17, 2007·BMC Public Health·Jen-Huoy TsayNicole Huang
Dec 17, 2009·BMC Public Health·Nera AgabitiUNKNOWN Italian Study Group on Inequalities in Health Care
Aug 18, 2006·BMC Health Services Research·Denise Cloutier-FisherEric-Bené F Druyts
Oct 13, 2006·BMC Health Services Research·Fredric D WolinskyGary E Rosenthal
Nov 28, 2006·BMC Health Services Research·Margaret J McGregorMichelle B Cox
Sep 1, 2007·BMC Health Services Research·Paolo RizzaItalo F Angelillo
Feb 20, 2008·BMC Health Services Research·Purificacion MaganJose Manuel Ribera
May 17, 2006·International Journal of Health Geographics·Lee R MobleyJulia Koschinsky
Apr 24, 2003·Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association·Michael SeidJames W Varni
Nov 18, 2003·Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association·John F SteinerArthur J Davidson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.